250 related articles for article (PubMed ID: 36641157)
41. CRISPR/Cas12a-Based Diagnostic Platform Accurately Detects
Qiu X; Xu S; Liu X; Ren H; Han L; Li Z
Front Cell Infect Microbiol; 2022; 12():884411. PubMed ID: 35719360
[TBL] [Abstract][Full Text] [Related]
42. A programmable and sensitive CRISPR/Cas12a-based MicroRNA detection platform combined with hybridization chain reaction.
Jia HY; Zhao HL; Wang T; Chen PR; Yin BC; Ye BC
Biosens Bioelectron; 2022 Sep; 211():114382. PubMed ID: 35605545
[TBL] [Abstract][Full Text] [Related]
43. Programmable RNA detection with CRISPR-Cas12a.
Rananaware SR; Vesco EK; Shoemaker GM; Anekar SS; Sandoval LSW; Meister KS; Macaluso NC; Nguyen LT; Jain PK
Nat Commun; 2023 Sep; 14(1):5409. PubMed ID: 37669948
[TBL] [Abstract][Full Text] [Related]
44. CRISPR/Cas12a-enhanced single-molecule counting for sensitive detection of flap endonuclease 1 activity at the single-cell level.
Zhao NN; Tian X; Ma F; Zhang CY
Chem Commun (Camb); 2023 Apr; 59(33):4939-4942. PubMed ID: 37013669
[TBL] [Abstract][Full Text] [Related]
45. CRISPR-Cas12a-based efficient electrochemiluminescence biosensor for ATP detection.
Xu ZH; Zhao ZY; Wang H; Wang SM; Chen HY; Xu JJ
Anal Chim Acta; 2021 Dec; 1188():339180. PubMed ID: 34794559
[TBL] [Abstract][Full Text] [Related]
46. Sensitive and selective DNA detecting electrochemical sensor via double cleaving CRISPR Cas12a and dual polymerization on hyperbranched rolling circle amplification.
You J; Park H; Lee H; Jang K; Park J; Na S
Biosens Bioelectron; 2023 Mar; 224():115078. PubMed ID: 36641878
[TBL] [Abstract][Full Text] [Related]
47. Low-Background CRISPR/Cas12a Sensors for Versatile Live-Cell Biosensing.
Li QN; Wang DX; Han GM; Liu B; Tang AN; Kong DM
Anal Chem; 2023 Oct; 95(42):15725-15735. PubMed ID: 37819747
[TBL] [Abstract][Full Text] [Related]
48. A CRISPR/Cas12a-assisted in vitro diagnostic tool for identification and quantification of single CpG methylation sites.
van Dongen JE; Berendsen JTW; Eijkel JCT; Segerink LI
Biosens Bioelectron; 2021 Dec; 194():113624. PubMed ID: 34534948
[TBL] [Abstract][Full Text] [Related]
49. Framework-Hotspot Enhanced Trans Cleavage of CRISPR-Cas12a for Clinical Samples Detection.
Li F; Li J; Yang W; Yang S; Chen C; Du L; Mei J; Tang Q; Chen X; Yao C; Yang D; Zuo X; Liu P
Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202305536. PubMed ID: 37278518
[TBL] [Abstract][Full Text] [Related]
50. Universal smartphone-assisted label-free CRISPR/Cas12a-DNAzyme chemiluminescence biosensing platform for on-site detection of nucleic acid and non-nucleic acid targets.
Chen H; Feng Y; Liu F; Tan C; Xu N; Jiang Y; Tan Y
Biosens Bioelectron; 2024 Mar; 247():115929. PubMed ID: 38128320
[TBL] [Abstract][Full Text] [Related]
51. Switching the Activity of CRISPR/Cas12a Using an Allosteric Inhibitory Aptamer for Biosensing.
Qin P; Chen P; Deng N; Tan L; Yin BC; Ye BC
Anal Chem; 2022 Nov; 94(45):15908-15914. PubMed ID: 36327313
[TBL] [Abstract][Full Text] [Related]
52. Aptamer assisted CRISPR-Cas12a strategy for small molecule diagnostics.
Niu C; Wang C; Li F; Zheng X; Xing X; Zhang C
Biosens Bioelectron; 2021 Jul; 183():113196. PubMed ID: 33839534
[TBL] [Abstract][Full Text] [Related]
53. Label-free fluorescence detection of human 8-oxoguanine DNA glycosylase activity amplified by target-induced rolling circle amplification.
Sun M; Chen X; Chen X; Zhou Q; Huang T; Li T; Xie B; Li C; Chen JX; Dai Z; Chen J
Anal Chim Acta; 2024 Jan; 1287():342084. PubMed ID: 38182379
[TBL] [Abstract][Full Text] [Related]
54. Nano-immunosorbent assay based on Cas12a/crRNA for ultra-sensitive protein detection.
Zhao Q; Pan Y; Luan X; Gao Y; Zhao X; Liu Y; Wang Y; Song Y
Biosens Bioelectron; 2021 Oct; 190():113450. PubMed ID: 34197999
[TBL] [Abstract][Full Text] [Related]
55. An ultrasensitive hybridization chain reaction-amplified CRISPR-Cas12a aptasensor for extracellular vesicle surface protein quantification.
Xing S; Lu Z; Huang Q; Li H; Wang Y; Lai Y; He Y; Deng M; Liu W
Theranostics; 2020; 10(22):10262-10273. PubMed ID: 32929347
[TBL] [Abstract][Full Text] [Related]
56. A ratiometric fluorescent biosensing platform for ultrasensitive detection of Salmonella typhimurium via CRISPR/Cas12a and silver nanoclusters.
Ma L; Wang J; Li Y; Liao D; Zhang W; Han X; Man S
J Hazard Mater; 2023 Feb; 443(Pt B):130234. PubMed ID: 36372024
[TBL] [Abstract][Full Text] [Related]
57. CRISPR-Cas12a Coupled with DNA Nanosheet-Amplified Fluorescence Anisotropy for Sensitive Detection of Biomolecules.
Xie TJ; Xie JL; Luo YJ; Mao K; Huang CZ; Li YF; Zhen SJ
Anal Chem; 2023 May; 95(18):7237-7243. PubMed ID: 37120835
[TBL] [Abstract][Full Text] [Related]
58. Programmable RNA detection with CRISPR-Cas12a.
Rananaware SR; Vesco EK; Shoemaker GM; Anekar SS; Sandoval LSW; Meister KS; Macaluso NC; Nguyen LT; Jain PK
Res Sq; 2023 Feb; ():. PubMed ID: 36824842
[TBL] [Abstract][Full Text] [Related]
59. Programmable RNA detection with CRISPR-Cas12a.
Rananaware SR; Vesco EK; Shoemaker GM; Anekar SS; Sandoval LSW; Meister KS; Macaluso NC; Nguyen LT; Jain PK
bioRxiv; 2023 Jan; ():. PubMed ID: 36778248
[TBL] [Abstract][Full Text] [Related]
60. CRISPR/Cas13a-triggered Cas12a biosensing method for ultrasensitive and specific miRNA detection.
Zhao D; Tang J; Tan Q; Xie X; Zhao X; Xing D
Talanta; 2023 Aug; 260():124582. PubMed ID: 37116358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
